- Home
- App Analytics
- GlucoWatch
- GlucoWatch Vs. Nightscout X
GlucoWatch vs Nightscout X Usage & Stats
GlucoWatch is an Apple Watch app dedicated to glucose monitoring, compatible with Abbott's FreeStyle Libre 2 and Libre 3 sensors.
Important: If you encounter any issues downloading the app, please download it directly from the App Store on your Apple Watch, not from your iPhone.
GlucoWatch displays real-time glucose data transmitted via the LibreLinkUp app directly on your watch face for convenient and discreet monitoring.
GlucoWatch is an independent, personally developed app with no affiliation to Abbott. The information displayed is not intended for medical use. Always refer to your official LibreLink or Libre 3 app, or perform a blood glucose test if you have any doubts about the data.
All trademarks, logos, and brand names are the property of their respective owners.
- Apple App Store
- Free
- Health & Fitness
Store Rank
- -
An alternative client of Nightscout, developed in Swift and optimized for the iPhone X.
* View your Nightscout web page with this app.
* Optimized for iPhone X but working perfect on any iPhone.
* Working perfect on iPad.
* Widget to see the glucose with the screen lock.
* App settings: prevent screen locking: with this option enabled, your device will not lock your screen automatically.
* App settings: lock screen rotation: with this option enabled, your device will not rotate the screen.
Nightscout project allow diabetics to see their glucose level in any connected device from their CGM device.
More information and how to set up your Nightscout web page in www.nightscout.info
- Apple App Store
- Free
- Health & Fitness
Store Rank
- -
GlucoWatch vs. Nightscout X ranking comparison
Compare GlucoWatch ranking trend in the past 28 days vs. Nightscout X
Rank
No Data Available
GlucoWatch vs. Nightscout X ranking by country comparison
Compare GlucoWatch ranking trend in the past 28 days vs. Nightscout X
No Data to Display
Compare to any site with our free trial
GlucoWatch VS.
Nightscout X
December 10, 2024